Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 24371208)

1.

Neomycin and pentagalloyl glucose enhanced cross-linking for elastin and glycosaminoglycans preservation in bioprosthetic heart valves.

Tripi DR, Vyavahare NR.

J Biomater Appl. 2014 Jan;28(5):757-66. doi: 10.1177/0885328213479047.

PMID:
24371208
2.

Neomycin and carbodiimide crosslinking as an alternative to glutaraldehyde for enhanced durability of bioprosthetic heart valves.

Leong J, Munnelly A, Liberio B, Cochrane L, Vyavahare N.

J Biomater Appl. 2013 May;27(8):948-60. doi: 10.1177/0885328211430542. Epub 2011 Dec 29.

PMID:
22207605
3.

Neomycin enhances extracellular matrix stability of glutaraldehyde crosslinked bioprosthetic heart valves.

Friebe VM, Mikulis B, Kole S, Ruffing CS, Sacks MS, Vyavahare NR.

J Biomed Mater Res B Appl Biomater. 2011 Nov;99(2):217-29. doi: 10.1002/jbm.b.31889. Epub 2011 Jun 28.

PMID:
21714085
4.

Neomycin fixation followed by ethanol pretreatment leads to reduced buckling and inhibition of calcification in bioprosthetic valves.

Raghavan D, Shah SR, Vyavahare NR.

J Biomed Mater Res B Appl Biomater. 2010 Jan;92(1):168-77. doi: 10.1002/jbm.b.31503.

5.

Degeneration of bioprosthetic heart valve cusp and wall tissues is initiated during tissue preparation: an ultrastructural study.

Simionescu DT, Lovekamp JJ, Vyavahare NR.

J Heart Valve Dis. 2003 Mar;12(2):226-34.

PMID:
12701796
6.

Neomycin binding preserves extracellular matrix in bioprosthetic heart valves during in vitro cyclic fatigue and storage.

Raghavan D, Starcher BC, Vyavahare NR.

Acta Biomater. 2009 May;5(4):983-92. doi: 10.1016/j.actbio.2008.11.004. Epub 2008 Nov 27.

7.

Neomycin prevents enzyme-mediated glycosaminoglycan degradation in bioprosthetic heart valves.

Raghavan D, Simionescu DT, Vyavahare NR.

Biomaterials. 2007 Jun;28(18):2861-8. Epub 2007 Mar 13.

8.

Role of elastin in pathologic calcification of xenograft heart valves.

Bailey MT, Pillarisetti S, Xiao H, Vyavahare NR.

J Biomed Mater Res A. 2003 Jul 1;66(1):93-102.

PMID:
12833435
9.

Calcification resistance of procyanidin-treated decellularized porcine aortic valves in vivo.

Liu Y, Liu W, Sun G, Wei X, Yi D.

Heart Surg Forum. 2009 Jan;12(1):E24-9. doi: 10.1532/HSF98.20081103.

PMID:
19233761
10.

Periodate-mediated glycosaminoglycan stabilization in bioprosthetic heart valves.

Lovekamp J, Vyavahare N.

J Biomed Mater Res. 2001 Sep 15;56(4):478-86.

PMID:
11400125
11.

Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration.

Simionescu DT, Lovekamp JJ, Vyavahare NR.

J Heart Valve Dis. 2003 Mar;12(2):217-25.

PMID:
12701795
12.

The effect of glycosaminoglycan stabilization on tissue buckling in bioprosthetic heart valves.

Shah SR, Vyavahare NR.

Biomaterials. 2008 Apr;29(11):1645-53. doi: 10.1016/j.biomaterials.2007.12.009. Epub 2008 Jan 15.

13.
14.

A novel crosslinking method for improved tear resistance and biocompatibility of tissue based biomaterials.

Tam H, Zhang W, Feaver KR, Parchment N, Sacks MS, Vyavahare N.

Biomaterials. 2015 Oct;66:83-91. doi: 10.1016/j.biomaterials.2015.07.011. Epub 2015 Jul 14.

PMID:
26196535
15.

Extracellular matrix degrading enzymes are active in porcine stentless aortic bioprosthetic heart valves.

Simionescu DT, Lovekamp JJ, Vyavahare NR.

J Biomed Mater Res A. 2003 Sep 15;66(4):755-63.

PMID:
12926026
16.

The effects of cross-link density and chemistry on the calcification potential of diamine-extended glutaraldehyde-fixed bioprosthetic heart-valve materials.

Bezuidenhout D, Oosthuysen A, Human P, Weissenstein C, Zilla P.

Biotechnol Appl Biochem. 2009 Nov;54(3):133-40.

PMID:
19882764
17.

Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves.

Lovekamp JJ, Simionescu DT, Mercuri JJ, Zubiate B, Sacks MS, Vyavahare NR.

Biomaterials. 2006 Mar;27(8):1507-18. Epub 2005 Sep 6.

18.

Tannic acid treatment enhances biostability and reduces calcification of glutaraldehyde fixed aortic wall.

Isenburg JC, Simionescu DT, Vyavahare NR.

Biomaterials. 2005 Apr;26(11):1237-45.

PMID:
15475053
19.

Viscoelasticity of dynamically fixed bioprosthetic valves. II. Effect of glutaraldehyde concentration.

Duncan AC, Boughner D, Vesely I.

J Thorac Cardiovasc Surg. 1997 Feb;113(2):302-10.

PMID:
9040624
20.

Biomechanical and ultrastructural comparison of cryopreservation and a novel cellular extraction of porcine aortic valve leaflets.

Courtman DW, Pereira CA, Omar S, Langdon SE, Lee JM, Wilson GJ.

J Biomed Mater Res. 1995 Dec;29(12):1507-16.

PMID:
8600141
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk